You are being invited to take part in a methodology study to collect samples that will be used to research new safety biomarkers for application in drug development. You will not personally derive any benefit from your participation in this study, but the results obtained could be very important for the development of medicines and treatments which will benefit other people.
Who may participate
This study is seeking healthy male or female participants, meaning that the participants will not have the condition being studied. In addition to the criteria listed, participants must meet the following requirements:
- Weight of 50 kg minimum
- Body Mass Index of 17.5 - 32 kg/m2 for participants of ≥ 65 years old
- Non-smoker, ex-smoker
- Able to meet all study visit requirements
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
The study is planned to last for approximately 8 weeks.
Several examinations or procedures will be required in connection with the study:
- A screening examination during which you will sign a COVID ICD and the study ICD.
- 3 ambulatory visits separated by an interval of approximately 14 days.
Interested in participating?
New to clinical research? If you’re interested in becoming a participant or need more information on the registration process, please complete and submit the registration form. We will contact you as soon as possible.
Already in our database? If you’d like to subscribe for this study, please contact us by phone.
Personal data means any information relating to you as a natural person such as for example your name, your date of birth, your telephone number or information relating to your health or your medical condition.
The personal data you share with us when completing the registration form is collected by the Brussels PCRU in order to send you the relevant literature and the medical questionnaire. It will be processed in a strictly confidential manner and in conformity with all applicable legislations, especially the European and Belgian laws applicable to clinical trials, and the European and Belgian laws applicable to personal data protection.
Personal data protection is very important to our clinical research unit. That’s why we ask that you read our Privacy Notice available at https://privacycenter.pfizer.com/en/belgium.